Is BioCryst Pharmaceuticals, Inc. technically bullish or bearish?

As of 11 September 2025, the technical trend for BioCryst Pharmaceuticals, Inc. has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, with key indicators driving this assessment including a bearish MACD on the weekly timeframe, bearish moving averages on the daily timeframe, and a bearish KST on the weekly timeframe. Additionally, both the Dow Theory and OBV indicate a mildly bearish trend on the weekly and monthly scales.
In terms of performance, the stock has underperformed compared to the S&P 500 over the past week and month, with returns of -1.36% and -5.01% respectively, while the S&P 500 gained 1.05% and 2.33%. However, year-to-date, the stock has a positive return of 5.85%, though it significantly lags behind the S&P 500's 12.22% return.